Selected research
Industry Research
Anxiety Relief Supplements Industry Research Report 2026
Market perspective
The global Anxiety Relief Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anxiety Relief Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anxiety Relief Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anxiety Relief Supplements include LONZA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Nestle S.A., Merck, The Nature's Bounty Co., Now Food, Nature's Sunshine and Herbalife, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anxiety Relief Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anxiety Relief Supplements Market by Company
LONZA
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Nestle S.A.
Merck
The Nature's Bounty Co.
Now Food
Nature's Sunshine
Herbalife
GNC
DuPont
DSM
Ayanda
Arkopharma
Amway Corporation
Abbott Laboratories
Anxiety Relief Supplements Segment by Type
Vitamin Supplements
Magnesium Supplements
L-Theanine Supplements
Other
Anxiety Relief Supplements Segment by Application
Clinic
Pharmacy
E-commerce Platform
Supermarket
Other
Anxiety Relief Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety Relief Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anxiety Relief Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety Relief Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anxiety Relief Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anxiety Relief Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anxiety Relief Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamin Supplements
- Magnesium Supplements
- L-Theanine Supplements
- Other
Applications
- Clinic
- Pharmacy
- E-commerce Platform
- Supermarket
- Other
Companies covered
- LONZA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Nestle S.A.
- Merck
- The Nature's Bounty Co.
- Now Food
- Nature's Sunshine
- Herbalife
- GNC
- DuPont
- DSM
- Ayanda
- Arkopharma
- Amway Corporation
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anxiety Relief Supplements Market Size (2021-2032)
- 2.2.2 Global Anxiety Relief Supplements Sales (2021-2032)
- 2.2.3 Global Anxiety Relief Supplements Market Average Price (2021-2032)
- 2.3 Anxiety Relief Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vitamin Supplements
- 2.3.3 Magnesium Supplements
- 2.3.4 L-Theanine Supplements
- 2.3.5 Other
- 2.4 Anxiety Relief Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Pharmacy
- 2.4.4 E-commerce Platform
- 2.4.5 Supermarket
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anxiety Relief Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anxiety Relief Supplements Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Anxiety Relief Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Anxiety Relief Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Anxiety Relief Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anxiety Relief Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anxiety Relief Supplements, Product Type & Application
- 3.8 Global Manufacturers of Anxiety Relief Supplements, Established Date
- 3.9 Global Anxiety Relief Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 LONZA
- 4.1.1 LONZA Company Information
- 4.1.2 LONZA Business Overview
- 4.1.3 LONZA Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 LONZA Anxiety Relief Supplements Product Portfolio
- 4.1.5 LONZA Recent Developments
- 4.2 Takeda Pharmaceutical Co. Ltd.
- 4.2.1 Takeda Pharmaceutical Co. Ltd. Company Information
- 4.2.2 Takeda Pharmaceutical Co. Ltd. Business Overview
- 4.2.3 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Product Portfolio
- 4.2.5 Takeda Pharmaceutical Co. Ltd. Recent Developments
- 4.3 Teva Pharmaceutical Industries Ltd.
- 4.3.1 Teva Pharmaceutical Industries Ltd. Company Information
- 4.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 4.3.3 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Product Portfolio
- 4.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 4.4 Nestle S.A.
- 4.4.1 Nestle S.A. Company Information
- 4.4.2 Nestle S.A. Business Overview
- 4.4.3 Nestle S.A. Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nestle S.A. Anxiety Relief Supplements Product Portfolio
- 4.4.5 Nestle S.A. Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Anxiety Relief Supplements Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 The Nature's Bounty Co.
- 4.6.1 The Nature's Bounty Co. Company Information
- 4.6.2 The Nature's Bounty Co. Business Overview
- 4.6.3 The Nature's Bounty Co. Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 The Nature's Bounty Co. Anxiety Relief Supplements Product Portfolio
- 4.6.5 The Nature's Bounty Co. Recent Developments
- 4.7 Now Food
- 4.7.1 Now Food Company Information
- 4.7.2 Now Food Business Overview
- 4.7.3 Now Food Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Now Food Anxiety Relief Supplements Product Portfolio
- 4.7.5 Now Food Recent Developments
- 4.8 Nature's Sunshine
- 4.8.1 Nature's Sunshine Company Information
- 4.8.2 Nature's Sunshine Business Overview
- 4.8.3 Nature's Sunshine Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nature's Sunshine Anxiety Relief Supplements Product Portfolio
- 4.8.5 Nature's Sunshine Recent Developments
- 4.9 Herbalife
- 4.9.1 Herbalife Company Information
- 4.9.2 Herbalife Business Overview
- 4.9.3 Herbalife Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Herbalife Anxiety Relief Supplements Product Portfolio
- 4.9.5 Herbalife Recent Developments
- 4.10 GNC
- 4.10.1 GNC Company Information
- 4.10.2 GNC Business Overview
- 4.10.3 GNC Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GNC Anxiety Relief Supplements Product Portfolio
- 4.10.5 GNC Recent Developments
- 4.11 DuPont
- 4.11.1 DuPont Company Information
- 4.11.2 DuPont Business Overview
- 4.11.3 DuPont Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 DuPont Anxiety Relief Supplements Product Portfolio
- 4.11.5 DuPont Recent Developments
- 4.12 DSM
- 4.12.1 DSM Company Information
- 4.12.2 DSM Business Overview
- 4.12.3 DSM Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 DSM Anxiety Relief Supplements Product Portfolio
- 4.12.5 DSM Recent Developments
- 4.13 Ayanda
- 4.13.1 Ayanda Company Information
- 4.13.2 Ayanda Business Overview
- 4.13.3 Ayanda Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Ayanda Anxiety Relief Supplements Product Portfolio
- 4.13.5 Ayanda Recent Developments
- 4.14 Arkopharma
- 4.14.1 Arkopharma Company Information
- 4.14.2 Arkopharma Business Overview
- 4.14.3 Arkopharma Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Arkopharma Anxiety Relief Supplements Product Portfolio
- 4.14.5 Arkopharma Recent Developments
- 4.15 Amway Corporation
- 4.15.1 Amway Corporation Company Information
- 4.15.2 Amway Corporation Business Overview
- 4.15.3 Amway Corporation Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Amway Corporation Anxiety Relief Supplements Product Portfolio
- 4.15.5 Amway Corporation Recent Developments
- 4.16 Abbott Laboratories
- 4.16.1 Abbott Laboratories Company Information
- 4.16.2 Abbott Laboratories Business Overview
- 4.16.3 Abbott Laboratories Anxiety Relief Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Abbott Laboratories Anxiety Relief Supplements Product Portfolio
- 4.16.5 Abbott Laboratories Recent Developments
5 Global Anxiety Relief Supplements Market Scenario by Region
- 5.1 Global Anxiety Relief Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anxiety Relief Supplements Sales by Region: 2021-2032
- 5.2.1 Global Anxiety Relief Supplements Sales by Region: 2021-2026
- 5.2.2 Global Anxiety Relief Supplements Sales by Region: 2027-2032
- 5.3 Global Anxiety Relief Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Anxiety Relief Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Anxiety Relief Supplements Revenue by Region: 2027-2032
- 5.4 North America Anxiety Relief Supplements Market Facts & Figures by Country
- 5.4.1 North America Anxiety Relief Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anxiety Relief Supplements Sales by Country (2021-2032)
- 5.4.3 North America Anxiety Relief Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anxiety Relief Supplements Market Facts & Figures by Country
- 5.5.1 Europe Anxiety Relief Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anxiety Relief Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Anxiety Relief Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anxiety Relief Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anxiety Relief Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anxiety Relief Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anxiety Relief Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anxiety Relief Supplements Market Facts & Figures by Country
- 5.7.1 South America Anxiety Relief Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anxiety Relief Supplements Sales by Country (2021-2032)
- 5.7.3 South America Anxiety Relief Supplements Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anxiety Relief Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anxiety Relief Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anxiety Relief Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anxiety Relief Supplements Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anxiety Relief Supplements Sales by Type (2021-2032)
- 6.1.1 Global Anxiety Relief Supplements Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Anxiety Relief Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Anxiety Relief Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Anxiety Relief Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anxiety Relief Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Anxiety Relief Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anxiety Relief Supplements Sales by Application (2021-2032)
- 7.1.1 Global Anxiety Relief Supplements Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Anxiety Relief Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Anxiety Relief Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Anxiety Relief Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anxiety Relief Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Anxiety Relief Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anxiety Relief Supplements Value Chain Analysis
- 8.1.1 Anxiety Relief Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anxiety Relief Supplements Production Mode & Process
- 8.2 Anxiety Relief Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anxiety Relief Supplements Distributors
- 8.2.3 Anxiety Relief Supplements Customers
9 Global Anxiety Relief Supplements Analyzing Market Dynamics
- 9.1 Anxiety Relief Supplements Industry Trends
- 9.2 Anxiety Relief Supplements Industry Drivers
- 9.3 Anxiety Relief Supplements Industry Opportunities and Challenges
- 9.4 Anxiety Relief Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst